ArticleThe journal of prevention of Alzheimer's disease2026
Reductions in neuropsychiatric symptoms after lecanemab treatment and their associations with imaging markers of β-amyloid clearance.
Yaping Yan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.